Search Results

Showing results 1 - 10 of 1320.
Sort By: Date ▼

AHL feature: Rx drug prices are causing ‘financial toxicity.’ Here’s how to address it.

October 19, 2017


Prescription drug prices continue to rise placing an increasing financial burden on patients and families—but industry experts outline three key steps providers can take to ease out-of-pocket costs for patients and reduce uncompensated care costs.

At hearing, sens. call for action to curb rising Rx drug prices

October 19, 2017


Sen. Patty Murray (D-Wash.) says, "We have to make more progress to get at the root of the problem facing patients, which is the high prices set by drug manufacturers."

Anthem to launch PBM in a partnership with CVS Health

October 19, 2017


Anthem says it has signed a five-year contract to partner with CVS Health to launch its own pharmacy-benefit manager after its contract with Express Scripts expires at the end of 2019.

Does DOJ have the tools to fight opioid misuse? Officials are going to find out.

October 19, 2017


U.S. Deputy Attorney General Rod Rosenstein says the Department of Justice is going to review whether current laws give the department enough power to curb the epidemic, following a "60 Minutes" and Washington Post investigation that found a 2016 law hinders the Drug Enforcement Administration's efforts to curb the amount of prescription painkillers distributed in the United States.

Alex Azar is the HHS secretary frontrunner, White House officials say

October 18, 2017


An anonymous White House official says President Trump has signed off on nominating Alex Azar, a former pharmaceutical industry CEO who had served as general counsel and deputy secretary at HHS under former President George W. Bush, for HHS secretary, but another official said the nomination would not be final until the White House issues a formal announcement.

Judge rules Allergan patents for Restasis are invalid

October 18, 2017


The ruling opens up the possibility that drugmakers could create generic versions of Allergan's best-selling eye drug Restasis, but Allergan says it will appeal the decision.

‘Drug czar’ nominee withdraws after report claims he backed law that curbs DEA’s opioid authority

October 17, 2017


Rep. Tom Marino (R-Pa.), whom President Trump had nominated to head the Office of National Drug Control Policy, is withdrawing from consideration after an investigation by "60 Minutes" and the Washington Post found that legislation authored by Marino and signed into law by former President Barack Obama has hindered the Drug Enforcement Administration's ability to halt opioid shipments.

FDA approves record number of generic drugs in FY 2017

October 17, 2017


FDA data show the agency in fiscal year (FY) 2017 approved 763 generic drugs, breaking the agency's previous record of 651 generic drug approvals in FY 2016.

Report: For the first time since 2014, health care spending drops below 4 percent

October 13, 2017


The Altarum Institute report finds the growth rate for health care services spending in the second quarter of 2017 fell to 3.5 percent, while hospital spending grew by 1.3 percent and prescription drug spending grew by 5.2 percent.

When it comes to the nocebo effect, the price of a drug matters, study finds

October 13, 2017


A. Vania Apkarian, a pain researcher at Northwestern University who was not involved in the study, says the research will advance how stakeholders look at the way biases influence health care.

Results Page: [Previous] 1 2 3 4 5  ... [Next]